Sleep disruption in hematopoietic cell transplantation recipients: Prevalence, severity, and clinical management

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 10, 2014, Pages 1465-1484

  Jim, Heather S L ^a   Evans, Bryan ^b   Jeong, Jiyeon M ^c   Gonzalez, Brian D ^a   Johnston, Laura ^c   Nelson, Ashley M ^b   Kesler, Shelli ^c   Phillips, Kristin M ^a   Barata, Anna ^a,d   Pidala, Joseph ^a   Palesh, Oxana ^c  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Hematopoietic cell transplant; Management of sleep disruption; Sleep disruption

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; MELATONIN RECEPTOR AGONIST;

ACUTE GRAFT VERSUS HOST DISEASE; COGNITIVE THERAPY; DELIRIUM; DISEASE SEVERITY; DRUG THERAPY; ENTERITIS; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; HUMAN; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; NAUSEA; OBSERVATIONAL STUDY; PATIENT EDUCATION; PREVALENCE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SLEEP DISORDER; SLEEP DISRUPTION; SLEEP MEDICINE; VOMITING; ALLOTRANSPLANTATION; COMPLICATION; CROSS-SECTIONAL STUDY; HEMATOLOGIC NEOPLASMS; PHYSIOTHERAPY; PROCEDURES; PSYCHOLOGY; PSYCHOTHERAPY; QUESTIONNAIRE; RESTLESS LEGS SYNDROME; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; SLEEP INITIATION AND MAINTENANCE DISORDERS;

CROSS-SECTIONAL STUDIES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALIZATION; HUMANS; PHYSICAL THERAPY MODALITIES; PSYCHOTHERAPY; QUALITY OF LIFE; QUESTIONNAIRES; RESTLESS LEGS SYNDROME; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; SLEEP INITIATION AND MAINTENANCE DISORDERS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84912520877     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.04.010     Document Type: Review

References (79)

1. Pasquini M.C., Wang Z., Horowitz M.M., Gale R.P. 2010 Report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. Clin Transpl 2010, 87-105.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2013, American Psychiatric Association, Washington, DC. 5th ed.
3. Bevans M.F., Mitchell S.A., Marden S. The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT). Support Care Cancer 2008, 16:1243-1254.
4. Rischer J., Scherwath A., Zander A.R., et al. Sleep disturbances and emotional distress in the acute course of hematopoietic stem cell transplantation. Bone Marrow Transplant 2009, 44:121-128.
5. Lee S.J., Joffe S., Kim H.T., et al. Physicians' attitudes about quality-of-life issues in hematopoietic stem cell transplantation. Blood 2004, 104:2194-2200.
6. Morgenthaler T., Alessi C., Friedman L., et al. Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep 2007, 30:519-529.
7. Enderlin C.A., Coleman E.A., Davila D., et al. Sleep measured by polysomnography in patients receiving high-dose chemotherapy for multiple myeloma prior to stem cell transplantation. Oncol Nurs Forum 2013, 40:73-81.
8. Beck S.L., Schwartz A.L., Towsley G., et al. Psychometric evaluation of the Pittsburgh Sleep Quality Index in cancer patients. JPain Symptom Manage 2004, 27:140-148.
9. Savard M.H., Savard J., Simard S., Ivers H. Empirical validation of the Insomnia Severity Index in cancer patients. Psychooncology 2005, 14:429-441.
10. Morin C.M. Insomnia: Psychological assessment and management 1993, Guilford Press, New York.
11. Buysse D.J., Reynolds C.F., Monk T.H., et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989, 28:193-213.
12. Johns M.W. Anew method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14:540-545.
13. Walters A.S., LeBrocq C., Dhar A., et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003, 4:121-132.
14. Monk T.H., Reynolds C.F., Kupfer D.J., et al. The Pittsburgh Sleep Diary. JSleep Res 1994, 3:111-120.
15. Calloway M., Bharmal M., Hill-Zabala C., Allen R. Development and validation of a subjective post sleep diary (SPSD) to assess sleep status in subjects with restless legs syndrome. Sleep Med 2011, 12:704-710.
16. Schutte-Rodin S., Broch L., Buysse D., et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. JClin Sleep Med 2008, 4:487-504.
17. Epstein L.J., Kristo D., Strollo P.J., et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. JClin Sleep Med 2009, 5:263-276.
18. Aurora R.N., Kristo D.A., Bista S.R., et al. The treatment of restless legs syndrome and periodic limb movement disorder in adults-an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses: an American Academy of Sleep Medicine Clinical Practice Guideline. Sleep 2012, 35:1039-1062.
19. Tsou Y.A., Cheng Y.K., Lin C.D., et al. Small B cell lymphocytic lymphoma presenting as obstructive sleep apnea. World J Surg Oncol 2004, 2:26.
20. Hjorth M., Hjertner O., Knudsen L.M., et al. Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study. Eur J Haematol 2012, 88:485-496.
21. Ostacoli L., Saini A., Ferini-Strambi L., et al. Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapy. Qual Life Res 2010, 19:531-537.
22. Sherman A.C., Simonton S., Latif U., et al. Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation. Biol Blood Marrow Transplant 2009, 15:12-20.
23. Frick E., Ramm G., Bumeder I., et al. Social support and quality of life of patients prior to stem cell or bone marrow transplantation. Br J Health Psychol 2006, 11:451-462.
24. Danaher E.H., Ferrans C., Verlen E., et al. Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant. Oncol Nurs Forum 2006, 33:614-624.
25. Frodin U., Borjeson S., Lyth J., Lotfi K. Aprospective evaluation of patients' health-related quality of life during auto-SCT: a 3-year follow-up. Bone Marrow Transplant 2011, 46:1345-1352.
26. Grulke N., Albani C., Bailer H. Quality of life in patients before and after haematopoietic stem cell transplantation measured with the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Core Questionnaire QLQ-C30. Bone Marrow Transplant 2011, 47:473-482.
27. Hacker E.D., Larson J.L., Peace D. Exercise in patients receiving hematopoietic stem cell transplantation: lessons learned and results from a feasibility study. Oncol Nurs Forum 2011, 38:216-223.
28. Cohen M.Z., Rozmus C.L., Mendoza T.R., et al. Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation. JPain Sympt Manage 2012, 44:168-180.
29. Gruber U., Fegg M., Buchmann M., et al. The long-term psychosocial effects of haematopoetic stem cell transplantation. Eur J Cancer Care 2003, 12:249-256.
30. Hacker E.D., Ferrans C.E. Quality of life immediately after peripheral blood stem cell transplantation. Cancer Nurs 2003, 26:312-322.
31. Anderson K.O., Giralt S.A., Mendoza T.R., et al. Symptom burden in patients undergoing autologous stem-cell transplantation. Bone Marrow Transplant 2007, 39:759-766.
32. Gulbrandsen N., Hjermstad M.J., Wisloff F. Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences. Eur J Haematol 2004, 72:172-180.
33. Hjermstad M.J., Knobel H., Brinch L., et al. Aprospective study of health-related quality of life, fatigue, anxiety and depression 3-5 years after stem cell transplantation. Bone Marrow Transplant 2004, 34:257-266.
34. Wettergren L., Sprangers M., Bjorkholm M., Langius-Eklof A. Quality of life before and one year following stem cell transplantation using an individualized and a standardized instrument. Psychooncology 2008, 17:338-346.
35. Sherman A.C., Coleman E.A., Griffith K., et al. Use of a supportive care team for screening and preemptive intervention among multiple myeloma patients receiving stem cell transplantation. Support Care Cancer 2003, 11:568-574.
36. Stiff P.J., Emmanouilides C., Bensinger W.I., et al. Palifermin reduces patient-reported mouth and throat soreness and improves patient functioning in the hematopoietic stem-cell transplantation setting. JClin Oncol 2006, 24:5186-5193.
37. Boonstra L., Harden K., Jarvis S., et al. Sleep disturbance in hospitalized recipients of stem cell transplantation. Clin J Oncol Nurs 2011, 15:271-276.
38. Gulbrandsen N., Wisloff F., Brinch L., et al. Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support. Med Oncol 2001, 18:65-77.
39. Diez-Campelo M., Perez-Simon J.A., Gonzalez-Porras J.R., et al. Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study. Bone Marrow Transplant 2004, 34:729-738.
40. Berger G., Hardak E., Shaham B., et al. Preliminary prospective explanatory observation on the impact of 3-month steroid therapy on the objective measures of sleep-disordered breathing. Sleep Breath 2012, 16:549-553.
41. Kraus P.D., Wolff D., Grauer O., et al. Muscle cramps and neuropathies in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease. PloS One 2012, 7:e44922.
42. Yeh P., Walters A.S., Tsuang J.W. Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment. Sleep Breath 2012, 16:987-1007.
43. Palesh O., Peppone L., Innominato P.F., et al. Prevalence, putative mechanisms, and current management of sleep problems during chemotherapy for cancer. Nat Sci Sleep 2012, 4:151-162.
44. Faulhaber G.A., Furlanetto T.W., Astigarraga C.C., et al. Association of busulfan and cyclophosphamide conditioning with sleep disorders after hematopoietic stem cell transplantation. Acta Haematol 2010, 124:125-128.
45. Hendriks M.G., Schouten H.C. Quality of life after stem cell transplantation: a patient, partner and physician perspective. Eur J Intern Med 2002, 13:52-56.
46. Worel N., Biener D., Kalhs P., et al. Long-term outcome and quality of life of patients who are alive and in complete remission more than 2 years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant 2002, 30:619-626.
47. Pallua S., Giesinger J., Oberguggenberger A., et al. Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation. Bone Marrow Transplant 2010, 45:1534-1539.
48. Andrykowski M.A., Bishop M.M., Hahn E.A., et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. JClin Oncol 2005, 23:599-608.
49. Bieri S., Roosnek E., Helg C., et al. Quality of life and social integration after allogeneic hematopoietic SCT. Bone Marrow Transplant 2008, 42:819-827.
50. Bishop M.M., Beaumont J.L., Hahn E.A., et al. Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. JClin Oncol 2007, 25:1403-1411.
51. Kopp M., Holzner B., Meraner V., et al. Quality of life in adult hematopoietic cell transplant patients at least 5 yr after treatment: a comparison with healthy controls. Eur J Haematol 2005, 74:304-308.
52. Syrjala K.L., Langer S.L., Abrams J.R., et al. Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. JClin Oncol 2005, 23:6596-6606.
53. Hayden P.J., Keogh F., Ni Conghaile M., et al. Asingle-centre assessment of long-term quality-of-life status after sibling allogeneic stem cell transplantation for chronic myeloid leukaemia in first chronic phase. Bone Marrow Transplant 2004, 34:545-556.
54. Roth T., Coulouvrat C., Hajak G., et al. Prevalence and perceived health associated with insomnia based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition criteria: results from the America Insomnia Survey. Biol Psychiatry 2011, 69:592-600.
55. Messerer D., Engel J., Hasford J., et al. Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia. Haematologica 2008, 93:826-833.
56. Mosher C.E., DuHamel K.N., Rini C., et al. Quality of life concerns and depression among hematopoietic stem cell transplant survivors. Support Care Cancer 2011, 19:1357-1365.
57. Kiss T.L., Abdolell M., Jamal N., et al. Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. JClin Oncol 2002, 20:2334-2343.
58. Savard J., Villa J., Ivers H., et al. Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month period. JClin Oncol 2009, 27:5233-5239.
59. Watson M., Buck G., Wheatley K., et al. Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients: analysis of the UK Medical Research Council AML 10 Trial. Eur J Cancer 2004, 40:971-978.
60. Boland E., Eiser C., Ezaydi Y., et al. Living with advanced but stable multiple myeloma: a study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life. JPain Symptom Manage 2013, 46:671-680.
61. Gallardo D., de la Camara R., Nieto J.B., et al. Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study. Haematologica 2009, 94:1282-1288.
62. NIH State-of-the-Science Conference Statement on manifestations and management of chronic insomnia in adults. NIH Consens State Sci Statements 2005, 22:1-30.
63. Savard J., Simard S., Ivers H., Morin C.M. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects. JClin Oncol 2005, 23:6083-6096.
64. Sommer M., Bachmann C.G., Liebetanz K.M., et al. Pregabalin in restless legs syndrome with and without neuropathic pain. Acta Neurol Scand 2007, 115:347-350.
65. Coleman E.A., Goodwin J.A., Kennedy R., et al. Effects of exercise on fatigue, sleep, and performance: a randomized trial. Oncol Nurs Forum 2012, 39:468-477.
66. Lee S.J., Le Rademacher J., Jim H.S., et al. Exercise and stress management training for patients undergoing autologous or allogeneic hematopoietic cell transplantation: Results from Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902. Blood 2013, 122:699.
67. Baumann F.T., Kraut L., Schule K., et al. Acontrolled randomized study examining the effects of exercise therapy on patients undergoing haematopoietic stem cell transplantation. Bone Marrow Transplant 2010, 45:355-362.
68. Baumann F.T., Zopf E.M., Nykamp E., et al. Physical activity for patients undergoing an allogeneic hematopoietic stem cell transplantation: benefits of a moderate exercise intervention. Eur J Haematol 2011, 87:148-156.
69. Jarden M., Baadsgaard M.T., Hovgaard D.J., et al. Arandomized trial on the effect of a multimodal intervention on physical capacity, functional performance and quality of life in adult patients undergoing allogeneic SCT. Bone Marrow Transplant 2009, 43:725-737.
70. Oechsle K., Aslan Z., Suesse Y., et al. Multimodal exercise training during myeloablative chemotherapy: a prospective randomized pilot trial. Support Care Cancer 2014, 22:63-69.
71. Jim H.S., Jacobsen P.B., Phillips K.M., et al. Lagged relationships among sleep disturbance, fatigue, and depressed mood during chemotherapy. Health Psychol 2013, 32:768-774.
72. Guariniello L.D., Vicari P., Lee K.S., et al. Bone marrow and peripheralwhite blood cells number is affected by sleep deprivation ina murine experimental model. JCell Physiol 2012, 227:361-366.
73. Sharda S., Carter J., Wingard J.R., Mehta P. Monitoring vital signs in a bone marrow transplant unit: are they needed in the middle of the night?. Bone Marrow Transplant 2001, 27:1197-1200.
74. Kolla B.P., Lovely J.K., Mansukhani M.P., Morgenthaler T.I. Zolpidem is independently associated with increased risk of inpatient falls. JHosp Med 2013, 8:1-6.
75. National Comprehensive Cancer Network. Clinical practice guidelines in oncology survivorship version 1.2013. Accessed August 27,2013. http://www.nccn.org/professionals/physician_gls/pdf/survivorship.pdf.
76. Costantini C., Ale-Ali A., Helsten T. Sleep aid prescribing practices during neoadjuvant or adjuvant chemotherapy for breast cancer. JPalliat Med 2011, 14:563-566.
77. De Souza C.A., Duraes M.I., Vigorito A.C., et al. Quality of life in patients randomized to receive a bone marrow or a peripheral blood allograft. Haematologica 2002, 87:1281-1285.
78. Harder H., Cornelissen J.J., Van Gool A.R., et al. Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation. Cancer 2002, 95:183-192.
79. Physicians' desk reference 2013 2012, PDR Staff, PDR Network, Montvale, NJ. 67 ed.